Stock listing

Gh Research Plc

Selected listing: GHRS · NASDAQ · USD · US

Gh Research Plc (NASDAQ:GHRS), Health Technology. Latest release Jun 4, 2026: GH Research Announces Publication of Phase 2a Postpartum Depression Results.

GHRS:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:GHRS
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Gh Research Plc

Gh Research Plc is a public company traded under the ticker GHRS in the American market. Gh Research is dedicated to advancing its research and product offerings to meet the needs of patients.

Latest news from Gh Research Plc

GH Research Announces Publication of Phase 2a Postpartum Depression Results

June 3, 2026

GH Research Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026

GH Research Announces Pricing of $117.5 Million Underwritten Offering

April 29, 2026

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

April 20, 2026

GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD

March 24, 2026

All Gh Research Plc news →

Research Gh Research Plc

Gh Research Plc company profile

View the public company page for Gh Research Plc on 6ix.

Gh Research Plc news

Read company news and market updates connected to Gh Research Plc.

Gh Research Plc investor events

Find investor webinars, events, and replay context for Gh Research Plc.